Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Montreal Heart Institute performs its first implant of new prosthesis for cardiac arrhythmia

01.12.2009
Universite de Montreal-affiliated MHI chosen to serve as a North American training center

A multidisciplinary team from the Montreal Heart Institute (MHI), which is affiliated to the Université de Montréal, performed its first catheter implantation of a new prosthesis (Amptlazer® Cardiac Plug) closing the appendage of the left atrium of the heart, which will have the effect of preventing the formation of blood clots and avoiding open-heart surgery.

This is excellent news for patients suffering from atrial fibrillation, the most common form of cardiac arrhythmia, affecting at least 5 percent of Canadians over the age of 70. This innovation takes place within the framework of a pan-Canadian program that includes the Institut de cardiologie et de pneumologie de Québec, the Toronto General Hospital, St. Paul's Hospital in Vancouver, as well as the MHI.

Pooling expertise, convincing results

The team that performed the first three procedures at the MHI on November 25, 2009, was composed of Drs. Réda Ibrahim, interventional cardiologist, Arsène Basmadjian, cardiologist and ultrasound specialist, and Antoine Rochon, anesthesiologist, all professors at the Université de Montréal, as well as Drs. Patrick Garceau, fellow in echocardiography, and Hasan Jilaihawi, fellow in interventional cardiology, plus nurses and a radiology technician. The results of the procedure were favourable for all three patients, who are well today. The members of the MHI team worked under the supervision of Dr. Rainer Schräder, head of the department of cardiology and intensive care unit at the Makus-Krankenhaus Centre in Frankfurt, Germany, the technique having already been used on a regular basis in Europe for over a year. Drs. Erick Horlick of the Toronto General Hospital and John G. Webb of St. Paul's Hospital in Vancouver were also present with a view to soon being able to perform similar procedures in their own institutions.

"We are delighted at being able to pool our expertise so as to offer a promising alternative to patients with atrial fibrillation and, in doing so, bring hope to these patients. By preventing clot formation, this prosthesis makes it possible to prevent cardiovascular accidents (CVA) and calls for a less invasive procedure in comparison to open heart surgery," said Dr. Réda Ibrahim.

Given its volume of activity and expertise in treating cardiovascular diseases, the MHI has also been chosen to serve as a training centre for American cardiologists who must be trained with a view to a study leading to approval of the prosthesis by the Federal Drug Administration (FDA). This training program will begin in early 2010.

About atrial fibrillation

Atrial fibrillation, the most common form of cardiac arrythmia, is associated with significant morbidity. One person in 20 will be affected by it at some point in their lives. Since it is more common in older people, the incidence of atrial fibrillation is rising as the population ages. From a clinical standpoint, it can cause palpitations, fatigue and syncope (fainting). Under normal conditions, the atria (the chambers of the heart that receive blood from the veins of the body and lungs) pump blood into the ventricles, which in turn pump it to the lungs and peripheral areas of the body (brain, kidneys, legs, etc.)

In atrial fibrillation, the atrial contractions become rapid and irregular. Blood can pool in the heart's chambers, which may lead to the formation of clots that can cause peripheral embolisms or strokes.

About the Montreal Heart Institute

Founded in 1954 by Dr. Paul David, the Montreal Heart Institute constantly aims for the highest standards of excellence in the cardiovascular field through its leadership in prevention, ultra-specialized care, training of professionals, clinical and fundamental research, and assessment of new technologies. It is affiliated with the Université de Montréal and its clinical outcomes are among the best in the world. To learn more about the Institute, please visit our website at www.icm-mhi.org.

About the Université de Montréal

Rooted in Montreal and international in its vocation, the Université de Montréal is one of the largest French-speaking universities in the world. Founded in 1878, the Université de Montréal includes 13 faculties and two professional schools. With its affiliated schools, HEC Montréal and École Polytechnique, the Université de Montréal is the leading centre for higher learning and research in Québec and one of the most important in North America. The Université de Montréal brings together some 2,500 teachers and researchers and is home to over 60, 000 students.

Doris Prince | EurekAlert!
Further information:
http://www.icm-mhi.org
http://www.umontreal.ca

More articles from Medical Engineering:

nachricht 3-D visualization of the pancreas -- new tool in diabetes research
15.03.2017 | Umea University

nachricht New PET radiotracer identifies inflammation in life-threatening atherosclerosis
02.03.2017 | Society of Nuclear Medicine

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Pulverizing electronic waste is green, clean -- and cold

22.03.2017 | Materials Sciences

Astronomers hazard a ride in a 'drifting carousel' to understand pulsating stars

22.03.2017 | Physics and Astronomy

New gel-like coating beefs up the performance of lithium-sulfur batteries

22.03.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>